Compara mètodes

	Mini-Mental State Examination	Escala d'Avaluació de la Malaltia d'Alzheimer-Cognitiva
Camp	Neuropsicologia	Neuropsicologia
Família	Process / pipeline	Process / pipeline
Any d'origen	1975	1984
Autor original	Marshall Folstein	William Rosen
Tipus	Clinician-administered cognitive screening instrument	Clinician-administered cognitive scale for Alzheimer's disease
Font seminal	Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198.	Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141(11), 1356-1364.
Àlies	MMSE, Folstein MMSE	ADAS-Cog, ADAS-Cog14, ADAS-Cog13
Relacionats	5	5
Resum	The Mini-Mental State Examination (MMSE) is a brief, 30-point screening instrument developed by Folstein, Folstein, and McHugh in 1975 to assess cognitive function in clinical settings. It is designed to detect cognitive impairment and monitor cognitive decline over time, particularly in older adults and patients with suspected dementia. The MMSE remains one of the most widely used cognitive screening tools in primary care, neurology, and geriatric medicine worldwide.	The Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) is a clinician-administered cognitive assessment instrument designed specifically to measure cognitive decline in Alzheimer's disease. Developed by Rosen, Mohs, and Davis in 1984 and published in the American Journal of Psychiatry, the ADAS-Cog has become the gold standard outcome measure in pharmaceutical trials of antidementia drugs. It is sensitive to disease progression and capable of detecting cognitive change over periods as brief as 6–12 months.